We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CLOV market cap is 1.76B. The company's latest EPS is USD -0.0842 and P/E is -40.86.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 510.93M | 346.92M | 356.26M | 330.99M | 356.93M |
| Operating Income | -65.66M | -22.7M | 7.19M | -8.79M | -1.48M |
| Net Income | -70.47M | -19.17M | 7.41M | -9.16M | -22.09M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.47B | 3.57B | 2.04B | 1.37B |
| Operating Income | -6.86M | -636.99M | -370.92M | -208.54M | -45.75M |
| Net Income | -6.75M | -587.76M | -338.84M | -213.36M | -43.01M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 570.67M | 671.77M | 674.21M | 653.01M | 580.74M |
| Total Liabilities | 284.28M | 379.3M | 349.32M | 310.85M | 239.6M |
| Total Equity | 286.39M | 292.47M | 324.89M | 342.17M | 341.14M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 856.42M | 950.8M | 808.62M | 570.67M | 580.74M |
| Total Liabilities | 62.91M | 411.49M | 460.88M | 284.28M | 239.6M |
| Total Equity | 5M | 539.32M | 347.74M | 286.39M | 341.14M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -115.87M | 25.94M | 70.69M | 120.68M | 34.85M |
| Investing | 140.01M | 9.19M | 14.14M | 2M | 565k |
| Financing | -33.86M | -3.36M | -6.55M | -11.22M | -17.36M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.23M | -282.33M | -203.93M | -115.87M | 34.85M |
| Investing | -828M | -435.45M | 95.13M | 140.01M | 565k |
| Financing | 858.23M | 925.39M | -4.96M | -33.86M | -17.36M |
| Market Cap | 1.76B |
| Price to Earnings Ratio | -40.86 |
| Price to Sales Ratio | 1.28 |
| Price to Cash Ratio | 9.03 |
| Price to Book Ratio | 5.15 |
| Dividend Yield | - |
| Shares Outstanding | 510.91M |
| Average Volume (1 week) | 5.14M |
| Average Volume (1 Month) | 6.08M |
| 52 Week Change | 403.65% |
| 52 Week High | 4.87 |
| 52 Week Low | 0.6251 |
| Spread (Intraday) | 0.01 (0.29%) |
| Company Name | Clover Health Investments Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cloverhealth.com |
| Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
